Conducting Trial-Based Economic Evaluations Using R: A Tutorial Ângela Jornada BenJohanna M. van DongenJudith E. Bosmans Practical Application Open access 17 July 2023 Pages: 1403 - 1413
Cost-Effectiveness of Emerging Treatments for Atopic Dermatitis: A Systematic Review Katja C. HeinzCharlotte BeaudartMickaël Hiligsmann Systematic Review Open access 01 July 2023 Pages: 1415 - 1435
Systematic Literature Review to Identify Cost and Resource Use Data in Patients with Early-Stage Non-small Cell Lung Cancer (NSCLC) Nick JovanoskiSeye AbogunrinLibby G. Jones Systematic Review Open access 30 June 2023 Pages: 1437 - 1452
Economic and Humanistic Burden of Osteoarthritis: An Updated Systematic Review of Large Sample Studies Xuejing JinWanxian LiangFeng Xie Systematic Review 18 July 2023 Pages: 1453 - 1467
A Systematic Review of Cost-Effectiveness Studies of Newer Non-Insulin Antidiabetic Drugs: Trends in Decision-Analytical Models for Modelling of Type 2 Diabetes Mellitus Henrik Vitus Bering LaursenEmmelie Ploug JørgensenLars Holger Ehlers Systematic Review Open access 06 July 2023 Pages: 1469 - 1514
EQ-5D-5L Value Set for Slovenia Valentina Prevolnik RupelMarko Ogorevc Original Research Article Open access 21 June 2023 Pages: 1515 - 1524
Development and Validation of txSim: A Model of Advanced Lung Cancer Treatment in Australia Preston NgoDeme KarikiosMarianne Weber Original Research Article Open access 25 June 2023 Pages: 1525 - 1537
Vaccinating the German Population Aged 60 Years and Over with a Quadrivalent High-Dose Inactivated Influenza Vaccine Compared to Standard-Dose Vaccines: A Transmission and Budget Impact Model Kathrin PahmeierChristian SpeckemeierJanine Biermann-Stallwitz Original Research Article Open access 11 July 2023 Pages: 1539 - 1550
Correction: Belimumab for Treating Active Autoantibody‑Positive Systemic Lupus Erythematosus: An Evidence Review Group Perspective of a NICE Single Technology Appraisal Thomas OttenRob RiemsmaSabine Grimm Correction Open access 04 September 2023 Pages: 1551 - 1551
